05:39 PM EDT, 05/13/2024 (MT Newswires) -- Atossa Therapeutics ( ATOS ) filed a shelf registration statement Monday covering the potential sale of $100 million of common and preferred shares, debt securities and warrants from time to time in one or more offerings.

The company plans to use the net proceeds from any sale of the securities mainly for general corporate purposes, according to a regulatory filing.

Price: 1.4500, Change: -0.01, Percent Change: -0.68